| P50 | author | Ingrid Laurendeau | Q114718300 |
| | Clément d'Audigier | Q114723640 |
| | Françoise Grelac | Q114723646 |
| | David M. Smadja | Q41895761 |
| | Ivan Bieche | Q56419632 |
| | Sophie Susen | Q56679064 |
| | Pascale Gaussem | Q57947811 |
| | Martine Aiach | Q75842644 |
| P2093 | author name string | Joseph Emmerich | |
| | Laetitia Mauge | |
| P2860 | cites work | International union of pharmacology. XXII. Nomenclature for chemokine receptors | Q28145705 |
| | Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis | Q28264314 |
| | Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood | Q28269379 |
| | Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury | Q28286412 |
| | Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 |
| | Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization | Q30876047 |
| | Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction | Q82458639 |
| | Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis | Q83091770 |
| | Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. | Q34286784 |
| | Cathepsin L is required for endothelial progenitor cell-induced neovascularization | Q34387265 |
| | Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals | Q34575418 |
| | IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis | Q34648364 |
| | Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice | Q35099565 |
| | Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells | Q35458444 |
| | Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6) | Q35459633 |
| | Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases | Q35551904 |
| | Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma | Q35747496 |
| | Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy. | Q36763667 |
| | Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice | Q37356393 |
| | PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. | Q40459317 |
| | Double transfection improves small interfering RNA-induced thrombin receptor (PAR-1) gene silencing in DU 145 prostate cancer cells | Q40495806 |
| | Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. | Q41231457 |
| | Interleukin-8. A corneal factor that induces neovascularization | Q42050315 |
| | Noncultured, autologous, skeletal muscle cells can successfully engraft into ovine myocardium | Q44480691 |
| | Detection of up-regulated genes in thrombin-stimulated human umbilical vein endothelial cells | Q46852488 |
| | CXC chemokines located in the 4q21 region are up-regulated in breast cancer. | Q46876505 |
| | The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. | Q50933010 |
| | Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. | Q51345347 |
| | Paracrine mitogenic effect of human endothelial progenitor cells: role of interleukin-8. | Q51513102 |
| | PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. | Q54645645 |
| | PAR-1 activation has different effects on the angiogenic activity of endothelial progenitor cells derived from human adult and cord blood | Q57767385 |
| | Thrombin stimulates production of interleukin-8 in human umbilical vein endothelial cells | Q71257938 |
| | IL-8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro | Q71705609 |
| | Inhibition of interleukin-8 reduces human malignant pleural mesothelioma propagation in nude mouse model | Q73194168 |
| | Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2 | Q78701428 |
| | IL-8 induces imbalances between nitric oxide and endothelin-1, and also between plasminogen activator inhibitor-1 and tissue-type plasminogen activator in cultured endothelial cells | Q79904704 |
| | Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation | Q80050896 |
| | Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases | Q81168941 |
| | Inflammation triggers colony forming endothelial cell mobilization after angioplasty in chronic lower limb ischemia | Q81397493 |
| | Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines | Q82385171 |
| P433 | issue | 8B | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 2534-2546 | |
| P577 | publication date | 2008-07-23 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells | |
| P478 | volume | 13 | |